Evolución y salud: evolución experimental y epidemiología
EVOSALUD
![Foto de Evolución y salud: evolución experimental y epidemiología](/img/grupo.png)
![Foto de Hospital General Universitario Gregorio Marañón](/img/noimage_org.png)
Hospital General Universitario Gregorio Marañón
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (27)
2023
-
Reporting antimicrobial susceptibilities and phenotypes of resistance to vancomycin in vancomycin-resistant Enterococcus spp. clinical isolates: A nationwide proficiency study
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 6, pp. 335-341
2022
-
Systematic Genomic and Clinical Analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfections and Recurrences Involving the Same Strain
Emerging Infectious Diseases, Vol. 28, Núm. 1, pp. 85-94
2021
-
Complete analysis of the epidemiological scenario around a sars-cov-2 reinfection: Previous infection events and subsequent transmission
mSphere, Vol. 6, Núm. 5
-
Different within-host viral evolution dynamics in severely immunosuppressed cases with persistent sars-cov-2
Biomedicines, Vol. 9, Núm. 7
-
Epidemiological, clinical and genomic snapshot of the first 100 B.1.1.7 SARS-CoV-2 cases in Madrid
Journal of travel medicine, Vol. 28, Núm. 4
-
Overlapping of Independent SARS-CoV-2 Nosocomial Transmissions in a Complex Outbreak
mSphere, Vol. 6, Núm. 4, pp. e0038921
-
Proper Assignation of Reactivation in a COVID-19 Recurrence Initially Interpreted as a Reinfection
The Journal of infectious diseases, Vol. 224, Núm. 5, pp. 788-792
-
Spread of a SARS-CoV-2 variant through Europe in the summer of 2020
Nature, Vol. 595, Núm. 7869, pp. 707-712
-
The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant
Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414
2019
-
Lower expression of plasma-derived exosome miR-21 levels in HIV-1 elite controllers with decreasing CD4 T cell count
Journal of Microbiology, Immunology and Infection, Vol. 52, Núm. 4, pp. 667-671
2017
-
Epidemiology and prognosis of candidaemia in elderly patients
Mycoses, Vol. 60, Núm. 12, pp. 808-817
-
Etestw versus broth microdilution for ceftaroline MIC determination with Staphylococcus aureus: Results from PREMIUM, a European multicentre study
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 2, pp. 431-436
-
Evaluation of the possible influence of trailing and paradoxical effects on the clinical outcome of patients with candidemia
Clinical Microbiology and Infection, Vol. 23, Núm. 1, pp. 49.e1-49.e8
-
Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance
Clinical Microbiology and Infection, Vol. 23, Núm. 9, pp. 672.e1-672.e11
2016
-
Empirical and targeted therapy of candidemia with fluconazole versus echinocandins: a propensity score–derived analysis of a population-based, multicentre prospective cohort
Clinical Microbiology and Infection, Vol. 22, Núm. 8, pp. 733.e1-733.e8
-
MicroRNA profile in CD8+ T-lymphocytes from HIV-infected individuals: Relationship with antiviral immune response and disease progression
PLoS ONE, Vol. 11, Núm. 5
2015
-
A simple prediction score for estimating the risk of candidaemia caused by fluconazole non-susceptible strains
Clinical Microbiology and Infection, Vol. 21, Núm. 7, pp. 684.e1-684.e9
-
Candida tropicalis bloodstream infection: Incidence, risk factors and outcome in a population-based surveillance
Journal of Infection, Vol. 71, Núm. 3, pp. 385-394
-
Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: RESULTS from a population-based surveillance in Spain
Clinical Microbiology and Infection, Vol. 21, Núm. 5, pp. 491.e1-491.e10
2014
-
Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: A population-based surveillance in Spain
Clinical Microbiology and Infection, Vol. 20, Núm. 4